P709-0265 Screening compound: 4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine

P709-0265 Screening compound: 4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine
P709-0265 Screening compound: 4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound P709-0265
4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P709-0265

Molecular Formula

C17H18N6O2S (C17 H18 N6 O2 S)

Compound Name

4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine

IUPAC name

4-{5-methyl-1-[5-(3-methyl-124-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}thiomorpholine

SMILES

Cc(n(-c(cc1)ncc1-c1nc(C)no1)nc1)c1C(N1CCSCC1)=O

InChI

InChI=1S/C17H18N6O2S/c1-11-14(17(24)22-5-7-26-8-6-22)10-19-23(11)15-4-3-13(9-18-15)16-20-12(2)21-25-16/h3-4,9-10H,5-8H2,1-2H3

InChI Key

KIABKMOYVVBLEJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613384

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.44

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.648

Distribution Coefficient, logD

1.646

Water Solubility, LogSw

-2.29

Polar Surface Area

70.843

Acid Dissociation Constant (pKa)

26.43

Base Dissociation Constant (pKb)

5.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.30

P709-0265 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P709-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P709-0265?
Check Price and Availability of P709-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P709-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P709-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P709-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P709-0265 available by request